NY-IFF
7.6.2023 22:19:27 CEST | Business Wire | Press release
IFF (NYSE: IFF) today announced that Yuvraj Arora, currently President, U.S. Categories for Kellogg North America, will join IFF as President, Nourish, effective June 19, 2023. Arora brings more than 25 years of multinational CPG experience to IFF’s Executive Leadership Team, mostly recently leading Kellogg’s $7 billion U.S. portfolio through a period of strong growth and portfolio transformation.
IFF today also announced the leadership structure to support the transition to a new operating model as part of the company’s transformation strategy. The shift from its current divisional structure to three core end markets—Food and Beverage, Home and Personal Care, and Health—will provide greater customer intimacy and enhance cross-functional collaboration, allowing for enhanced execution, speed and streamlined delivery. IFF expects its new operating model to be in effect by the beginning of 2024.
As President, Nourish, Arora, will lead IFF’s Food and Beverage categories when the operating model is in full effect in the new year. Arora has spent the past 21 years at Kellogg, beginning in India in 2002, where he held roles in marketing and category management. After relocating to the United States in 2005, he assumed roles of increasing responsibility in marketing, brand management and general management for the Cereals, Snacking and Salty Snack categories across the United States. From 2012-2015, he led marketing and innovation for the Asia, Middle East and Africa markets based out of Singapore. He most recently served as President, U.S. Categories for Kellogg North America, where he was responsible for leading the food giant’s U.S. portfolio across six categories.
Arora is a business leader with an excellent track record across multiple geographies, delivering significant portfolio and organizational transformation in support of driving Kellogg’s growth in multiple categories. An award-winning marketer, the depth and breadth of his experience spans brand and category management, product marketing, product innovation and general management.
“Yuvraj will be an outstanding addition to the leadership team,” said Frank Clyburn, CEO, IFF. “His expertise in commercializing innovation and track record of delivering strong P&L performance across food and beverage categories make him a great fit to lead Nourish. Yuvraj’s CPG and consumer insight experience will be of tremendous value as we continue to innovate and create with our customers to enable growth. His deep experience in driving transformation and execution will be instrumental in facilitating IFF’s previously announced transition to a category-backed operating model.”
Arora holds a Bachelor of Technology in Engineering from National Institute of Technology, Calicut and an MBA in Marketing from the University of Delhi, India. He will be based in IFF’s New York headquarters.
IFF also introduced a new divisional leadership structure in alignment with the company’s transformation strategy and new operating model:
Christophe Fauchon de Villeplee, currently President, Scent, will leave IFF after a period of transition. His career at IFF spans more than 24 years, with a total of 30 years in the industry. Since joining IFF in 1999, he held positions of increasing responsibility, including sales, group country management, regional general management of fragrances, North America, and global leadership of Fine Fragrances and Consumer Fragrances.
“We thank Christophe for his service to IFF and wish him the best for his future endeavors,” said Clyburn.
Simon Herriott, currently President, Health & Biosciences, will assume additional responsibilities in leading the Scent division. Herriott will lead IFF’s Home and Personal Care categories when the new operating model is in effect. Since 2019, Herriott has served as platform leader, Health & Biosciences. In a 16-year career with DuPont, Herriott held various leadership positions including in Industrial Biosciences Sustainable Solutions and Chemical Solutions businesses. During his career, he also held multiple roles at ICI, Zeneca and Avecia Inc. in Europe, Asia and North America.
Angela Strzelecki, currently President, Pharma Solutions, will lead IFF’s Health categories when the new operating model is in effect. Over a nearly 30-year career with DuPont, Strzelecki has held a variety of general management, operational and leadership positions across the company, including in Nutrition and Health, Corporate M&A, Titanium Technologies, Building Innovations, Corporate Strategy and Performance Coatings.
IFF will continue to operate in its current business structure for the remainder of 2023, while planning the transition to the new operating model in January 2024.
“Our evolution to a category-aligned operating model is a pivotal moment for IFF,” said Frank Clyburn, IFF CEO. “These proven leaders and the changes we are making will better enable us to bring the full value of the IFF portfolio to our customers, while deepening our commitment to customers and operational excellence. I am confident that our team and enhanced operating framework will benefit our customers, investors, colleagues and the global community of consumers, and position us to execute on IFF’s ambitious growth plans.”
Welcome to IFF
At IFF (NYSE: IFF), an industry leader in food, beverage, scent, health and biosciences, science and creativity meet to create essential solutions for a better world. With the beauty of art and the precision of science, we are an international collective of thinkers who partners with customers to bring scents, tastes, experiences, ingredients and solutions for products the world craves. Together, we will do more good for people and planet. Learn more at iff.com, Twitter , Facebook, Instagram, and LinkedIn.
© 2023 by International Flavors & Fragrances Inc. IFF is a Registered Trademark. All Rights Reserved.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230607005808/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Alipay Launches Next-Generation AI Payment Infrastructure, Debuts AI Wallet and Token Pay to Power Agentic Economy26.5.2026 17:20:00 CEST | Press release
Alipay today introduced its full-stack AI payment solution to partners across industries, ranging from AI companies to traditional retailers, and debuted two new services — the world’s first AI Wallet and Token Pay — to support the agentic economy’s rapid growth. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260526337824/en/ Alipay Unveils Next-generation AI Payment Infrastructure This launch extends Alipay's next-generation AI payment infrastructure, building on its consumer-facing product Alipay AI Pay and its business-facing AI payment processing product. “While the essence of commerce remains unchanged in the age of AI, the emergence of AI agents is reshaping everything. Drawing on 22 years of technological expertise and commercial know-how, Alipay is building a new generation of AI payment services to accelerate the growth of the agentic commerce ecosystem,” said Cyril Han, CEO of Ant Group. AI Wallet: Giving Users Vis
Daiichi Sankyo Europe Reaffirms Commitment to Patient-Centred Care with Extensive Data Showcase at EAS Congress 202626.5.2026 17:00:00 CEST | Press release
Presentations at the 94th European Atherosclerosis Society (EAS) Congress highlight the breadth of evidence for bempedoic acid across a wide range of patient subgroups and background therapies. Real-world data from the MILOS study across multiple European cohorts demonstrate consistent effectiveness and safety profile in routine clinical practice.1,2,3,4 Analysis from the CLEAR Outcomes trial underscores the impact of bempedoic acid on cardiovascular risks, including stroke and venous thromboembolism (VTE).5,6 Daiichi Sankyo Europe’s commitment to "care for every heartbeat" is centred on providing accessible oral treatment options to ensure every patient is given a chance to reach their LDL-C goals. Daiichi Sankyo Europe (DSE) is pleased to announce its extensive scientific presence at the European Atherosclerosis Society (EAS) Congress 2026. The presentation of 15 abstracts, comprising both clinical trial analyses and real-world evidence, underscores the company's sustained investment
OpenRouter Raises $113 Million CapitalG-led Series B as Weekly Volume Explodes to 25T Tokens26.5.2026 15:15:00 CEST | Press release
NVentures, ServiceNow Ventures, MongoDB Ventures, Snowflake Ventures, Databricks Ventures join CapitalG, a16z, Menlo Ventures, and others in backing the high-growth AI infrastructure startup OpenRouter, the AI model exchange, today announced a $113 million Series B led by Alphabet’s independent growth fund, CapitalG, with participation from investors including NVentures (NVIDIA’s venture capital arm), ServiceNow Ventures, MongoDB Ventures, Snowflake Ventures, Databricks Ventures, alongside existing investors including Andreessen Horowitz and Menlo Ventures. OpenRouter’s volume has surged to 25 trillion tokens per week (100 trillion tokens per month), representing a 5X increase from the 5 trillion tokens processed per week just six months ago. The explosion in token demand illustrates how quickly enterprises are deploying agents and scaling AI across multiple models and providers. OpenRouter’s infrastructure manages and optimizes inference and provides access to 400+ models across leadi
Xsolla Expands Its Community Management Tools for Creators, Community Leaders, and Resellers26.5.2026 15:00:00 CEST | Press release
Xsolla Adds New Features For Creators, Community Leader Experience, And Distinct Channels For Emerging Markets Xsolla, a leading global video game commerce company, today announced three simultaneous expansions of its community management tools and products. As the creator economy continues to reshape how games are discovered and the industry accelerates its shift toward direct-to-consumer commerce, Xsolla is building on its community management tools for creators, community leaders, and emerging markets, and will showcase them at TwitchCon Rotterdam later this month. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260526596720/en/ Graphic: Xsolla The games industry has never had a shortage of people who drive player acquisition, loyalty, and commerce; it's had a shortage of infrastructure that recognizes them. Creators stream it. Community leaders build a culture around it. Local resellers get it into the hands of players in
Biocytogen Launches AI-Powered RenSuper™ Platform and Industry-First Fully Automated Antibody Discovery Infrastructure26.5.2026 14:00:00 CEST | Press release
Biocytogen today announced the launch of RenSuper Workstation, a next-generation AI-powered antibody discovery platform providing off-the-shelf access to a large-scale, experimentally validated library of fully human therapeutic antibody sequences, together with the RenSuper High-Throughput Antibody Manufacturing Automation Center, a fully automated infrastructure designed to accelerate antibody validation and production. Built on Biocytogen’s proprietary RenMice® platforms, RenSuper establishes a closed-loop antibody discovery engine combining in vivo immune repertoires, AI-driven candidate selection, automated experimental validation, and scalable manufacturing infrastructure. The platform supports the discovery and development of monoclonal antibodies, bispecifics, multispecifics, antibody-drug conjugates (ADCs), VHHs, and other advanced therapeutic modalities, significantly reducing the time and risk associated with antibody discovery. RenSuper Workstation: AI-Powered One-Click Tar
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
